These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The clinical spectrum of dermatomyositis and the new autoantibodies - with regard to two clinical cases with distinct associations. Calvão da Silva JCM; Santiago L; Brites MM; Gonçalo M Australas J Dermatol; 2020 May; 61(2):e241-e243. PubMed ID: 31881093 [TBL] [Abstract][Full Text] [Related]
13. Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report. De Backer E; Gremonprez F; Brusselle G; Depuydt P; Van Dorpe J; Van Haverbeke C; Goeminne PC; Derom E Acta Clin Belg; 2018 Dec; 73(6):413-417. PubMed ID: 29287518 [TBL] [Abstract][Full Text] [Related]
14. Three cases of autoimmune-associated haemophagocytic syndrome in dermatomyositis with anti-MDA5 autoantibody. Honda M; Moriyama M; Kondo M; Kumakura S; Sumita Y; Murakawa Y Scand J Rheumatol; 2020 May; 49(3):244-246. PubMed ID: 31571515 [No Abstract] [Full Text] [Related]
15. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum. Yashiro M; Asano T; Sato S; Kobayashi H; Watanabe H; Miyata M; Migita K Fukushima J Med Sci; 2018; 64(2):89-94. PubMed ID: 30158335 [TBL] [Abstract][Full Text] [Related]
16. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis. Sakamoto S; Okamoto M; Kaieda S; Fujimoto K; Nagata S; Tominaga M; Nakamura M; Zaizen Y; Nouno T; Koga T; Kawayama T; Kuwana M; Ida H; Hoshino T Respir Investig; 2018 Nov; 56(6):464-472. PubMed ID: 30150008 [TBL] [Abstract][Full Text] [Related]
17. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease. Yoshida N; Okamoto M; Kaieda S; Fujimoto K; Ebata T; Tajiri M; Nakamura M; Tominaga M; Wakasugi D; Kawayama T; Kuwana M; Mimori T; Ida H; Hoshino T Respir Investig; 2017 Jan; 55(1):24-32. PubMed ID: 28012490 [TBL] [Abstract][Full Text] [Related]
18. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report. Quintana-Ortega C; Remesal A; Ruiz de Valbuena M; de la Serna O; Laplaza-González M; Álvarez-Rojas E; Udaondo C; Alcobendas R; Murias S Mod Rheumatol Case Rep; 2021 Jan; 5(1):101-107. PubMed ID: 33019894 [TBL] [Abstract][Full Text] [Related]
19. Rapidly progressive interstitial lung fibrosis in a patient with amyopathic dermatomyositis and anti‑MDA5 antibodies. Górka J; Szczeklik W; Włudarczyk A; Łoboda P; Chmura Ł; Musiał J Pol Arch Med Wewn; 2015; 125(9):685-6. PubMed ID: 26200801 [No Abstract] [Full Text] [Related]
20. Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer. Yamaoka T; Doi C; Yokomi A; Tanemura A; Murota H; Tani M; Saruban H; Hamaguchi Y; Fujimoto M; Katayama I Eur J Dermatol; 2014; 24(4):490-1. PubMed ID: 25075604 [No Abstract] [Full Text] [Related] [Next] [New Search]